159 related articles for article (PubMed ID: 12110490)
1. The frequency of breast cancer screening: results from the UKCCCR Randomised Trial. United Kingdom Co-ordinating Committee on Cancer Research.
Breast Screening Frequency Trial Group
Eur J Cancer; 2002 Jul; 38(11):1458-64. PubMed ID: 12110490
[TBL] [Abstract][Full Text] [Related]
2. Mammographic surveillance in women younger than 50 years who have a family history of breast cancer: tumour characteristics and projected effect on mortality in the prospective, single-arm, FH01 study.
FH01 collaborative teams
Lancet Oncol; 2010 Dec; 11(12):1127-34. PubMed ID: 21093374
[TBL] [Abstract][Full Text] [Related]
3. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial.
Miller AB; Wall C; Baines CJ; Sun P; To T; Narod SA
BMJ; 2014 Feb; 348():g366. PubMed ID: 24519768
[TBL] [Abstract][Full Text] [Related]
4. Screening for breast cancer detects tumours at an earlier biological stage.
Crisp WJ; Higgs MJ; Cowan WK; Cunliffe WJ; Liston J; Lunt LG; Peakman DJ; Young JR
Br J Surg; 1993 Jul; 80(7):863-5. PubMed ID: 8369918
[TBL] [Abstract][Full Text] [Related]
5. A trial to study the effect on breast cancer mortality of annual mammographic screening in women starting at age 40. Trial Steering Group.
Moss S
J Med Screen; 1999; 6(3):144-8. PubMed ID: 10572845
[TBL] [Abstract][Full Text] [Related]
6. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years.
Miller AB; Baines CJ; To T; Wall C
CMAJ; 1992 Nov; 147(10):1477-88. PubMed ID: 1423088
[TBL] [Abstract][Full Text] [Related]
7. Update of the Swedish two-county program of mammographic screening for breast cancer.
Tabàr L; Fagerberg G; Duffy SW; Day NE; Gad A; Gröntoft O
Radiol Clin North Am; 1992 Jan; 30(1):187-210. PubMed ID: 1732926
[TBL] [Abstract][Full Text] [Related]
8. Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial.
Duffy SW; Vulkan D; Cuckle H; Parmar D; Sheikh S; Smith RA; Evans A; Blyuss O; Johns L; Ellis IO; Myles J; Sasieni PD; Moss SM
Lancet Oncol; 2020 Sep; 21(9):1165-1172. PubMed ID: 32800099
[TBL] [Abstract][Full Text] [Related]
9. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years.
Miller AB; Baines CJ; To T; Wall C
CMAJ; 1992 Nov; 147(10):1459-76. PubMed ID: 1423087
[TBL] [Abstract][Full Text] [Related]
10. Effect of population breast screening on breast cancer mortality up to 2005 in England and Wales: an individual-level cohort study.
Johns LE; Coleman DA; Swerdlow AJ; Moss SM
Br J Cancer; 2017 Jan; 116(2):246-252. PubMed ID: 27931047
[TBL] [Abstract][Full Text] [Related]
11. The Gothenburg Breast Screening Trial.
Bjurstam N; Björneld L; Warwick J; Sala E; Duffy SW; Nyström L; Walker N; Cahlin E; Eriksson O; Hafström LO; Lingaas H; Mattsson J; Persson S; Rudenstam CM; Salander H; Säve-Söderbergh J; Wahlin T
Cancer; 2003 May; 97(10):2387-96. PubMed ID: 12733136
[TBL] [Abstract][Full Text] [Related]
12. Screening for breast cancer in women aged under 50: mode of detection, incidence, fatality, and histology.
Tabar L; Fagerberg G; Chen HH; Duffy SW; Gad A
J Med Screen; 1995; 2(2):94-8. PubMed ID: 7497163
[TBL] [Abstract][Full Text] [Related]
13. [Tailored Breast Screening Trial (TBST)].
Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
[TBL] [Abstract][Full Text] [Related]
14. New Swedish breast cancer detection results for women aged 40-49.
Tabar L; Duffy SW; Burhenne LW
Cancer; 1993 Aug; 72(4 Suppl):1437-48. PubMed ID: 8339236
[TBL] [Abstract][Full Text] [Related]
15. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
Lynge E
APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
[TBL] [Abstract][Full Text] [Related]
16. Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years.
Miller AB; To T; Baines CJ; Wall C
J Natl Cancer Inst; 2000 Sep; 92(18):1490-9. PubMed ID: 10995804
[TBL] [Abstract][Full Text] [Related]
17. Pathology characteristics that optimize outcome prediction of a breast screening trial.
Anderson TJ; Alexander FE; Lamb J; Smith A; Forrest AP
Br J Cancer; 2000 Aug; 83(4):487-92. PubMed ID: 10945496
[TBL] [Abstract][Full Text] [Related]
18. Role of detection method in predicting breast cancer survival: analysis of randomized screening trials.
Shen Y; Yang Y; Inoue LY; Munsell MF; Miller AB; Berry DA
J Natl Cancer Inst; 2005 Aug; 97(16):1195-203. PubMed ID: 16106024
[TBL] [Abstract][Full Text] [Related]
19. Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011.
Morrell S; Taylor R; Roder D; Robson B; Gregory M; Craig K
Br J Cancer; 2017 Mar; 116(6):828-839. PubMed ID: 28183141
[TBL] [Abstract][Full Text] [Related]
20. Influence of number of views and mammographic film density on the detection of invasive cancers: results from the NHS Breast Screening Programme.
Young KC; Wallis MG; Blanks RG; Moss SM
Br J Radiol; 1997 May; 70(833):482-8. PubMed ID: 9227229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
